Public recall detail

Venlafaxine XR Product Recall (2019-12-20)

medium
Recall Safety notice
Quick summary

Quick summary: Venlafaxine XR Product Recall (2019-12-20) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Venlafaxine XR Product Recall (2019-12-20) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionVenlafaxine XR 37.5 mg Capsule DIN, NPN, DIN-HIM DIN 02354713 Dosage form Capsule (Extended Release) Strength Venlafaxine hydrochloride 37.5 mg Lot or serial number W05930 Companies Recalling Firm Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA Marketing Authorization Holder Sanis Health 243 Consumers Road Toronto M2J 4W8 Ontario CANADA B. Teva-Venlafaxine XR 150 mg Capsule DIN, NPN, DIN-HIM DIN 02275058 Dosage form Capsule (Extended Release) Strength Venlafaxine hydrochloride 150 mg Lot or serial number W07930 Companies Recalling Firm Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA Marketing Authorization Holder Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...